Portfolio

Our capital, experience and infrastructure in China allow us to provide the resources and support to our portfolio companies for conducting clinical trials, making successful regulatory submissions, commercialization and manufacturing in this dynamic market.

We focus on innovation in the Biotech and MedTech fields that can best address China’s long-term development of its healthcare systems. Since 2016 we show a consistent track record of applying our unique investment model. To date we have established numerous JV companies in China in partnership with world-renowned Israeli and European companies.

Moreover, our associated Guangzhou-based life sciences incubator (link to BIG’s website) has allowed us to cater to start-ups, entrepreneurs and scientists developing cutting-edge technologies suited to the Chinese market. Under our multinational incubator program, we invest and support local and international companies in R&D and company formation.